Table 2.

CME Morphologic Characteristics in the Study Eyes

Characteristic	Eyes, No. (%)
	Eyes With CME	Progression to Laser Treatment in Study Eyes With CME		Vascular Outcome in Study Eyes With CME			Maximum ROP Stage in Study Eyes With CME
		No	Yes	No Plus	Pre-plus	Plus	Stage 0	Stage 1	Stage 2	Stage 3
Eyes, Total No. (%)	21 (100)	14 (67)	7 (33)	11 (52)	4 (19)	6 (29)	3 (14)	1 (5)	8 (38)	9 (43)
Quantity
Single	1 (5)	1 (7)	0 (0)	1 (9)	0 (0)	0 (0)	0	0	1 (12)	0
Multiple	20 (95)	13 (93)	7 (100)	10 (91)	4 (100)	6 (100)	3 (100)	1 (100)	7 (88)	9 (100)
Shape
Predominantly round	4 (19)	1 (7)	1 (14)	2 (18)	1 (25)	1 (17)	1 (33)	0	1 (12)	2 (22)
Predominantly elongated	17 (81)	13 (93)	6 (86)	10 (91)	3 (75)	5 (83)	2 (67)	1 (100)	7 (88)	7 (78)
Lateral location
Foveal only	1 (5)	1 (7)	0 (0)	1 (9)	0 (0)	0 (0)	0 (0)	0	1 (12)	0
Parafoveal only	4 (19)	3 (21)	1 (14)	1 (9)	2 (50)	1 (17)	1 (33)	0	1 (12)	2 (22)
Continuous	16 (76)	10 (72)	6 (86)	9 (82)	2 (50)	5 (83)	2 (67)	1 (100)	6 (75)	7 (78)
Axial location
INL only	21 (100)	14 (100)	7 (100)	11 (100)	4 (100)	6 (100)	3 (100)	1 (100)	8 (100)	9 (100)
INL and PRL	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0 (0)	0	0	0	0
Foveal contour
Deep	4 (19)	3 (21)	1 (14)	2 (18)	1 (25)	1 (17)	1 (33)	0 (0)	2 (25)	1 (11)
Shallow	4 (19)	4 (29)	0 (0)	3 (27)	1 (25)	0 (0)	1 (33)	0 (0)	2 (25)	1 (11)
Bulging	13 (62)	7 (50)	6 (86)	6 (55)	2 (50)	5 (83)	1 (33)	1 (100)	4 (50)	7 (78)

Abbreviations: CME, cystoid macular edema; INL, inner nuclear layer; PRL, photoreceptor layer; ROP, retinopathy of prematurity.